Clinical trial NCT06383364: The Effect of a Medication Coordinator on the Quality of Patients Medication Treatment
Official title: The Effect of a Medication Coordinator on the Quality of Patients Medication Treatment (MEDCOOR) - Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: ENROLLING_BY_INVITATION
Phase: NA
Conditions: Medication Review
Polypharmacy
Potentially Inappropriate Medication
Quality of Life
Medication Therapy Management
Keywords: Polypharmacy
Medication review
Patient care management
Empowerment
Potentially inappropriate medication list
Hospital to home transition
Medication quality
medication optimization
Treatment burden
Lead sponsor: University of Southern Denmark
Sponsor class: OTHER
First posted: 2024-04-25
Enrollment: 140
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: To examine the effect of a Medication Coordinator, who facilitates medication reviews in close collaboration with patients using My Medication Plan to reduce the risk of post-hospital inappropriate medication usage.

Detailed description: Patients' safety can be compromised in the transition of care between healthcare sectors. Optimal information flow across healthcare sectors and individualized medication treatment tailored to each patient is key to prevent adverse events and optimize patient treatment. Particularly, the inclusion of the general practitioner is important in this process; it could become a challenge to keep medication changes if this communication link is missing. The framework for complex intervention allows flexibility and adaption in meeting patients' needs by implementing tailored, possibly complex interventions in different healthcare settings. To examine the effect of a Medication Coordinator, who facilitates medication reviews in close collaboration with patients using My Medication Plan. The primary outcome is the proportion of potentially inappropriate medications. Secondary outcomes include patient-reported outcomes i.e., quality of life and medication burden. Additional outcomes include the patient's individual Medication Risk Score, if the patients are readmitted, and if the patients have contacted the staff at the hospital unit after the hospital discharge.

Eligibility criteria: Inclusion Criteria:

* all hospitalized patients, who are prescribed at least five medications specified in the Electronic Patient Journal (EPJ) used at ward

Exclusion Criteria:

* unable to communicate in Danish, cognitively impaired e.g. suffering from dementia or Alzheimer's, or cannot cooperate due to e.g. hallucination or aggressive behavior

Primary outcomes:
measure: Change in potentially inappropriate medication according to Potentially Inappropriate Medication List
timeFrame: Baseline and 6 months
Secondary outcomes:
measure: Evaluation of patients experiences quality of life with the EQ-5D and EQ-VAS.
timeFrame: Baseline and 3 months
measure: Evaluation of patients experienced quality of life with visual analogue scale (VAS).
timeFrame: Baseline and 3 months
measure: Evaluation of patients experienced treatment burden with the questionnaire Multimorbidity treatment burden questionnaire (MTBQ).
timeFrame: Baseline and 3 months
measure: Evaluation of patients experienced medication burden with visual analogue scale (VAS).
timeFrame: Baseline and 3 months
measure: Patient readmission 30 days after hospital discharge
timeFrame: 30 days after the patient has been discharged from the hospital.
measure: Patient contact to the ward 30 days after hospital discharge
timeFrame: 30 days after the patient has been discharged from the hospital.
Other outcomes:
Locations:
city: Aabenraa
country: Denmark
facility: Sygehus Sønderjylland
state: Southern Denmark
Study officials:
References: